KRAS alterations are frequently found in human cancers1, with G12C mutations occurring in 13% of non-small cell lung cancer (NSCLC) and 3% of colorectal cancer (CRC)1. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.